Watch Dean Ween Join Claypool Lennon For The Best ‘Southbound Pachyderm’ Ever

first_imgEdit this setlist | More The Claypool Lennon Delirium setlists On June 18th, 2016, The Claypool Lennon Delirium wrapped up a smooth sailing summer tour leg with a performance at the renowned Capitol Theatre in Port Chester, NY. With Dean Ween Group on as opening support, the two bands each provided a unique flavor of psychedelia for the night. The opening set even saw Les Claypool reprise his role from the night before, joining the Dean Ween Group on “The Mollusk.” The real special treat from last night’s show came in the encore, however, when Ween paid it forward.[Video by Brosef Wilson]After a rocking set that included most of the band’s new album The Monolith of Phobos, the set ended with spacey versions of Pink Floyd’s “Astronomy Domine,” “Captain Lariat,” and The Beatles’ “Tomorrow Never Knows.”Finally, the band welcomed out their first-ever guest, as Dean Ween plugged in after a few minutes of the hit Primus tune, “Southbound Pachyderm.” From there, the three string players – Ween, Lennon, and Claypool – were locked in as tightly as can be. It was an extraordinary moment of psychedelic musicianship, one captured brilliantly by Rey Mdo. Enjoy.Setlist: Dean Ween Group at The Capitol Theatre, Port Chester, NY – 6/18/16Dickey Betts, It’s gonna be a Long Night (DD on vocals), Garry*, Stella Blue, I Saw Gener Crying in his Sleep*, Fingerbang, Mercedes Benz, The Mollusk (with Les Claypool), The Rift*Joe on acousticlast_img read more

How credit unions piggyback marketing on Amazon Prime Day

first_img continue reading » Amazon Prime Day has become a cultural phenomenon in the short time since the ecommerce company created it. The now two-day event is part megasale, part brand marketing event, and part Prime account recruiting drive, all rolled into one. It may be one of the most successful commerce-created “holidays” ever. Amazon promised over a million deals globally.It’s a big day for financial institutions and their products, as well, because all those juicy bargains consumers slaver over have to be paid for. Prime Day generated an estimated $4.19 billion in sales globally in 2018 and Coresight Research projects it could hit $5.8 billion in 2019.Numerous consumer websites and even some business sites go bargain crazy, publishing tips and tricks for maximizing discounts and gaming the various cash back, percentage-off, rewards granting, price protection and other variations on payment card features during Prime Day and similar events.“Marketed almost as much, if not more, than Black Friday, Amazon Prime Day has forced financial services brands to shift their marketing strategy and create buzz ahead of time,” writes Alexa Dalessandro, Research Analyst at Comperemedia, a Mintel Company, in a recent report. 1SHARESShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblrlast_img read more

Moderna’s COVID-19 vaccine worked well in monkeys: Study

first_imgIn the Moderna animal study, three groups of eight rhesus macaques received either a placebo or the vaccine at two different dose levels — 10 micrograms and 100 micrograms.All vaccinated macaques produced high levels of neutralizing antibodies that attack a part of the SARS-CoV-2 virus used to invade cells.Notably, monkeys receiving both dose levels produced these antibodies at levels higher than those found in humans who have recovered from COVID-19.The authors reported that the vaccine also induced the production of a different immune cell known as T-cells that may have helped boost the overall response. Topics : US biotech firm Moderna’s COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys, a study in the New England Journal of Medicine said Tuesday.The fact that the vaccine prevented the virus from replicating in the nose is seen as particularly crucial in preventing it from being transmitted onward to others. The same outcome did not occur when the University of Oxford’s vaccine was tested on monkeys, though that vaccine did prevent the virus from entering the animals’ lungs and making them very sick.center_img A major area of concern is that vaccines under development could actually backfire by amplifying rather than suppressing the disease.So-called vaccine-associated enhancement of respiratory disease (VAERD) has been linked to the production of a specific type of T-cell known as Th2 — but these cells were not produced during the experiment, suggesting this vaccine won’t backfire.Four weeks after the monkeys received their second injection, they were exposed to the SARS-CoV-2 virus, both through the nose and directly to the lungs via a tube.After two days, no replicating virus was detected in the lungs of seven of the eight macaques in both the low and high dose groups.By contrast, all eight in the placebo group continued to have the virus present.None of the eight macaques in the high dose groups had detectable levels of virus in their noses two days after exposure. “This is the first time an experimental COVID-19 vaccine tested in nonhuman primates has been shown to produce such rapid viral control in the upper airway,” said the National Institutes for Health, which co-developed the vaccine.A COVID-19 vaccine capable of stopping the virus in the lungs will prevent the disease from becoming severe, while stopping the virus from replicating in the nose would lessen transmission.The Moderna vaccine uses genetic material in the form of viral RNA to encode the information needed to grow the SARS-CoV-2 spike protein inside the human body to trigger an immune response.Spike proteins give coronaviruses their crown-like appearance and are used to invade human cells, but by themselves are thought to be relatively harmless.The advantage of this technology is that it bypasses the need to manufacture viral proteins in the lab, helping to ramp up mass production.Both Moderna’s vaccine and the vaccine co-developed by the University of Oxford and AstraZeneca have entered late-stage human trials.last_img read more

FPSO tender for SNE field slated for 1Q 2018

first_imgPhase 1 development SNE drilling The joint venture achieved a concept select decision at the end of 2017 and entered concept definition. The Phase 1 development concept for the SNE field is a stand-alone FPSO facility with subsea infrastructure. It will be designed to allow subsequent SNE development phases, including options for potential gas export to shore and for future subsea tiebacks from other reservoirs and fields.Phase 1 will include oil production as well as gas and water injection wells. The expected FPSO oil production capacity is approximately 100,000 bbl/day. Gas sales opportunities are being explored to support incremental gas export to shore.According to Woodside, expressions of interest have been sought and subsequent engagement held with contractors and operators for subsea and FPSO facilities prior to a formal tendering process, expected in 1Q 2018. The joint venture is considering a redeployed FPSO facility as the preferred development opportunity.In August 2017, the environmental baseline survey was completed and the Environment and Social Impact Assessment (ESIA) process started. The joint venture is targeting submission of the ESIA in 2Q 2018.Work is progressing on detailed concept definition work which will lead to front-end engineering and design beginning in 4Q 2018, in parallel with anticipated approval of the Exploitation Plan.As reported earlier by Offshore Energy Today, the final investment decision (FID) for the project is targeted for early 2019. First oil from SNE is expected in 2022. Indicative FPSO facility and subsea layout for the SNE Field Development-Phase 1Partners in the SNE field development offshore Senegal have achieved a concept select decision and the tendering process for the FPSO and subsea facilities is expected in the first quarter of 2018. Cairn Energy is the operator of three blocks offshore Senegal (Rufisque, Sangomar and Sangomar Deep (RSSD)). The Sangomar Deep portion of offshore Senegal PSC contains the SNE field. Cairn’s partners off Senegal are Woodside, FAR Limited, and Petrosen.Woodside has been active in the offshore region of Senegal since 2016 when it acquired a material position in the SNE field from ConocoPhillips. In 2017, Woodside became Development Lead for the SNE Field Development-Phase 1 and plans to transition to operator of the RSSD blocks in 2018. Woodside’s participation in the acreage offshore Senegal was challenged by partner FAR.Woodside said in its annual report for 2017 on Wednesday that for early commercialization and ongoing optimization of the development plan, a phased development is proposed, focusing first on the less complex lower reservoir units. Subsequent phases will target more complex reservoir units, the company said. Appraisal drilling continued in 2017, improving the understanding of the reservoir and the optimal development plan.The 2017 drilling campaign on the Senegalese acreage was completed with five exploration and appraisal wells drilled ahead of schedule and under budget. Data from the campaign is currently being analysed to inform future activities.The joint venture is now reviewing potential 2018 drilling opportunities, including a prospect in the shallow water Rufisque offshore block. The forecast drilling activity plan schedules this activity for the fourth quarter of 2018.Offshore Energy Today Stafflast_img read more

Angels at White Sox: Thursday game time, TV channel, starting pitchers

first_imgTHE PITCHERSANGELS RHP BUD NORRIS (2-6, 4.42)vs. White Sox: 1-3, 4.64At Guaranteed Rate Field: 1-1, 2.79Hates to face: None ANGELS at WHITE SOXWhen: 5 p.m.Where: Guaranteed Rate FieldTV: Fox Sports West Newsroom GuidelinesNews TipsContact UsReport an Errorcenter_img Loves to face: NoneWHITE SOX RHP DYLAN COVEY (0-7, 7.83)vs. Angels: First gameAt Guaranteed Rate Field: 0-1, 4.70Hates to face: NoneLoves to face: Nonelast_img